Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

February 7, 2026

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

  • BTK Inhibitors
    /
  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
February 7, 2026 – Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of…
BTK Inhibitors

February 3, 2026

Congress Approves Funding for MS Research Program, PBM Reforms and More

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • National MS Society Related
    /
February 3, 2026 On February 3, 2026, Congress passed a bipartisan FY2026 funding package that included the following: Department of…
MS Research Study and Reports

February 3, 2026

Study Supported by the National Multiple Sclerosis Society Sheds Light on the Brain’s Ongoing Effort to Create Myelin-Making Cells

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Myelin Repair
    /
January 29, 2026 Researchers from Johns Hopkins Medicine discovered that the brain is continually trying to produce myelin-making cells. Supporting…
MS Research Study and Reports

February 3, 2026

New biomarker may help identify MS patients for BTK inhibitors

  • MS BIOMARKERS
    /
  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Balance between 2 molecules seen as inflammation marker Written by Marisa Wexler, MS | January 7, 2026 The balance between two immune signaling…
MS BIOMARKERS

February 3, 2026

BTK inhibitors match Aubagio at reducing relapse rates in MS: Review

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Further studies needed to determine if they provide lasting benefits Written by Margarida Maia, PhD | February 3, 2026 Experimental Bruton’s tyrosine kinase…
MS Drug Therapies

February 1, 2026

Female sexual dysfunction in multiple sclerosis

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
How big is the problem? Can it be effectively managed? Key points Prevalence and impact on quality of life Sexual…
Multiple Sclerosis

January 28, 2026

Disability, not age, drives cognitive impairment in MS adults: Study

  • Aging & MS
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Still, older adults experience more and worse problems than younger patients Written by Steve Bryson, PhD | January 28, 2026 Older adults with multiple…
Aging & MS

January 28, 2026

Experimental Treatments for Multiple Sclerosis

  • Marketing
    /
CNM-Au8 is an experimental oral therapy for relapsing and progressive forms of MS designed to boost nerve health and improve…
Marketing

January 28, 2026

EBV can trick the immune system to attack myelin in at-risk individuals

  • MS Relapse
    /
  • MS Relapse-Exacerbation
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Study shows how a common virus and genetic risk factors interact to trigger MS Written by Marisa Wexler, MS | January 15, 2026…
MS Relapse

January 28, 2026

New research findings challenge old beliefs about myelin repair in MS

  • Multiple Sclerosis
    /
  • Myelin Repair
    /
• New research findings challenge old beliefs about myelin repair in MS Written by Marisa Wexler, MS | January 28, 2026 Oligodendrocytes, the…
Multiple Sclerosis

Categories

Latest Blog Posts